€302.00
0.82%
Paris, Sep 24, 05:35 pm CEST.
ISIN
FR0000031577
Symbol
VIRP

Virbac Target price 2026 - Analyst rating & recommendation

Virbac Classifications & Recommendation

Buy
73%
Hold
20%
Sell
7%

Virbac Price Target

Target Price €421.77
Price €302.00
Potential
Number of Estimates 11
11 Analysts have issued a price target Virbac 2027 . The average Virbac target price is €421.77. This is higher than the current stock price. The highest price target is
€462.00 52.98%
register free of charge
, the lowest is
€363.60 20.40%
register free of charge
.
A rating was issued by 15 analysts: 11 Analysts recommend Virbac to buy, 3 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Virbac stock has an average upside potential 2027 of . Most analysts recommend the Virbac stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2029

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Billion € 1.46 1.58
4.82% 8.01%
EBITDA Margin 19.81% 20.50%
3.31% 3.49%
Net Margin 10.30% 11.21%
0.92% 8.81%

11 Analysts have issued a sales forecast Virbac 2026 . The average Virbac sales estimate is

€1.6b
unlock
. This is
8.01% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€1.6b 12.24%
unlock
, the lowest is
€1.5b 1.80%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 €1.5b 4.82%
2026
€1.6b 8.01%
unlock
2027
€1.7b 6.19%
unlock
2028
€1.8b 5.30%
unlock
2029
€1.9b 6.27%
unlock

11 Analysts have issued an Virbac EBITDA forecast 2026. The average Virbac EBITDA estimate is

€324m
unlock
. This is
11.76% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€344m 18.71%
unlock
, the lowest is
€301m 3.83%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 €290m 1.35%
2026
€324m 11.76%
unlock
2027
€358m 10.37%
unlock
2028
€390m 8.88%
unlock
2029
€409m 4.96%
unlock

EBITDA Margin

2025 19.81% 3.31%
2026
20.50% 3.49%
unlock
2027
21.30% 3.90%
unlock
2028
22.03% 3.43%
unlock
2029
21.75% 1.27%
unlock

12 Virbac Analysts have issued a net profit forecast 2026. The average Virbac net profit estimate is

€177m
unlock
. This is
17.52% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
€189m 25.38%
unlock
, the lowest is
€163m 7.98%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 €151m 3.85%
2026
€177m 17.52%
unlock
2027
€197m 11.13%
unlock
2028
€217m 10.05%
unlock
2029
€212m 2.10%
unlock

Net Margin

2025 10.30% 0.92%
2026
11.21% 8.81%
unlock
2027
11.73% 4.64%
unlock
2028
12.26% 4.52%
unlock
2029
11.29% 7.91%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2029

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share € 18.00 21.16
3.81% 17.56%
P/E 14.27
EV/Sales 1.72

12 Analysts have issued a Virbac forecast for earnings per share. The average Virbac EPS is

€21.16
unlock
. This is
17.56% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
€22.58 25.44%
unlock
, the lowest is
€19.44 8.00%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 €18.00 3.81%
2026
€21.16 17.56%
unlock
2027
€23.52 11.15%
unlock
2028
€25.88 10.03%
unlock
2029
€25.34 2.09%
unlock

P/E ratio

Current 16.78 196.27%
2026
14.27 14.95%
unlock
2027
12.84 10.02%
unlock
2028
11.67 9.11%
unlock
2029
11.92 2.14%
unlock

Based on analysts' sales estimates for 2026, the Virbac stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.85
2026
1.72 7.17%
unlock
2027
1.62 5.83%
unlock
2028
1.54 5.03%
unlock
2029
1.45 5.91%
unlock

P/S ratio

Current
2026
1.61 7.41%
unlock
2027
1.52 5.84%
unlock
2028
1.44 5.03%
unlock
2029
1.36 5.90%
unlock

Current Virbac Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BNP PARIBAS
Locked
➜
Locked
Locked Sep 22 2026
STIFEL EUROPE
Locked
➜
Locked
Locked Sep 21 2026
TP ICAP
Locked
➜
Locked
Locked Sep 21 2026
ODDO BHF
Locked
➜
Locked
Locked Sep 18 2026
JEFFERIES
Locked
➜
Locked
Locked Sep 17 2026
BAADER EUROPE / ALPHAVALUE
Locked
➜
Locked
Locked Sep 03 2026
JEFFERIES
Locked
➜
Locked
Locked Jul 09 2026
Analyst Rating Date
Locked
BNP PARIBAS:
Locked
➜
Locked
Sep 22 2026
Locked
STIFEL EUROPE:
Locked
➜
Locked
Sep 21 2026
Locked
TP ICAP:
Locked
➜
Locked
Sep 21 2026
Locked
ODDO BHF:
Locked
➜
Locked
Sep 18 2026
Locked
JEFFERIES:
Locked
➜
Locked
Sep 17 2026
Locked
BAADER EUROPE / ALPHAVALUE:
Locked
➜
Locked
Sep 03 2026
Locked
JEFFERIES:
Locked
➜
Locked
Jul 09 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today